Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Europe (Supplemental) | 2021

The COVID-19 pandemic will negatively impact the European GI endoscopy device market. Once the market stabilizes, however, it will grow modestly through 2029, due primarily to the saturation of this space, a lack of innovation in most device segments, and relatively low reimbursement for GI endoscopy across Europe. Market expansion will be driven by procedure volume growth and the introduction of novel devices in the capsule endoscope and Barrett’s esophagus ablation device markets.

This Medtech 360 Report provides key market metrics for the GI endoscopy device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Gastrointestinal Endoscopy Devices – Market Insights – Latin America
The Latin American GI endoscopy devices market is projected to grow moderately through 2034, driven by ongoing innovation in both diagnostic and interventional applications of GI endoscopy…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…